EUDRAGENE

First published 04/06/2010

Last updated 20/08/2024

Network

Download as PDF

Network identification

PURI: https://redirect.ema.europa.eu/resource/2392

Network ID: 2392

Network name and Acronym: EUDRAGENE

Network countries: France
Italy
Netherlands
Spain
Sweden
United Kingdom

Network website: https://www.eudragene.org/

ENCePP partner: No

Network description

The specific objectives of this study is to establish a collection of DNA samples as a resource for studying genes which influence serious or adverse drug reactions (ADRs). Identifying genes that influence susceptibility to adverse reactions will advance understanding of the basis of adverse drug reactions and may also lead to the development of tests that can predict individual susceptibility to adverse reactions,with obvious benefits to human health.

Network details

Network primary therapeutic area:

Other

Network funding:

EU institutional research programme

Other